IP50-24: Clinical Outcomes of Nadofaragene Firadenovac in BCG Unresponsive NMIBC: A Multi-Center analysis
Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!